Vertical Research Downgrades RXO to Hold, Announces $23 Price Target
Portfolio Pulse from Benzinga Newsdesk
Jeffrey Kauffman, an analyst at Vertical Research, has downgraded RXO (NYSE:RXO) from Buy to Hold and set a price target of $23.
January 10, 2024 | 3:37 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
RXO was downgraded from Buy to Hold by Vertical Research, with a new price target of $23.
Downgrades typically lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The new price target of $23 provides a reference point that may influence investor expectations and trading behavior.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100